GIKLY News and Press, Grifols SA Barcelona ADR

2026-03-03 15:20:30 ET More on Spanish stocks Banco Santander, S.A. (SAN) Analyst/Investor Day Transcript Banco Santander: The Risk-Reward Proposition Has Not Improved Much Following Recent Events Grifols, S.A. (GIKLY) Q4 2025 Earnings Call Transcript Webster...

2026-02-26 17:27:54 ET Grifols, S.A. (GIKLY) Q4 2025 Earnings Call February 26, 2026 12:30 PM EST Company Participants Daniel Segarra - Head of Investor Relations & Sustainability and Vice President Jose Ignacio Abia Buenache - CEO & Director Roland Wandele...

2026-01-26 21:15:00 ET The following segment was excerpted from the White Falcon Capital Q4 And FY 2025 Partner Letter. ... Read the full article on Seeking Alpha For further details see: White Falcon: Q4 2025 Portfolio Positions

2025-12-08 12:02:09 ET I've been a frequent analyst for covering Grifols, S.A. ( GRFS ) as a business here on Seeking Alpha. The world's largest blood plasma business, with other adjacent/related businesses, is going through a renaissance, rising like a phoenix from the ashes of wha...

2025-11-05 16:11:15 ET Grifols, S.A. (GIKLY) Q3 2025 Earnings Call November 4, 2025 12:30 PM EST Company Participants Daniel Segarra - Head of Investor Relations & Sustainability and Vice President Jose Ignacio Abia Buenache - CEO & Director Roland Wandeler...

2025-10-06 13:29:00 ET On September 17 , the Fed began cutting interest rates again, which historically preceded Big Pharma's increased activity in the M&A space.... Read the full article on Seeking Alpha For further details see: My Top 5 Biotech Stocks Big Pharm...

2025-07-18 07:05:40 ET We return to Grifols ( GRFS ) with a fresh review, following our previously neutral stance, which reflected a balance of encouraging progress and lingering concerns. As a reminder, we reported many question marks , and even if the company's leverage an...

2025-05-12 16:51:03 ET Grifols, S.A. (GRFS) Q1 2025 Earnings Conference Call May 12, 2025, 12:30 PM ET Company Participants Danny Segarra - VP, IR and Sustainability Nacho Abia - CEO Rahul Srinivasan - CFO Roland Wandeler - President Biopharma ...

2025-04-23 11:10:00 ET Summary Grifols, a Spanish multinational specializing in plasma-derived therapies, is undervalued due to historical mismanagement but holds a strong market position with significant competitive advantages. New management has implemented an operational improv...

2025-04-23 10:50:00 ET Summary The White Falcon portfolio underperformed due to losses in larger positions, despite gains from gold and silver royalties; Converge Technologies was acquired at a premium. Market volatility increased post-quarter due to President Trump's tariff annou...